DLD Antikörper (AA 459-509)
Kurzübersicht für DLD Antikörper (AA 459-509) (ABIN7453411)
Target
Alle DLD Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 459-509
-
Verwendungszweck
- Rabbit anti-DLD Antibody, Affinity Purified
-
Homologie
- Dog,Orangutan
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Between AA 459 and 509
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IHC: 1:1,000 - 1:5,000. Epitope retrieval with citrate buffer pH 6.0 is recommended for FFPE tissue sections.
IP: 2 - 10 μg/mg lysate
WB: 1:1,000 - 1:5,000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1000 μg/mL
-
Buffer
- Tris-citrate/phosphate buffer, pH 7 to 8 containing 0.09 % Sodium Azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Haltbarkeit
- 12 months
-
-
- DLD (Dihydrolipoamide Dehydrogenase (DLD))
-
Andere Bezeichnung
- DLD
-
Hintergrund
- Background: Dihydrolipoamide dehydrogenase (DLD) is a member of the class-I pyridine nucleotide-disulfide oxidoreductase family. DLD has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. In homodimeric form, DLD functions as a dehydrogenase and is found in several multi-enzyme complexes that regulate energy metabolism. However, as a monomer, this protein can function as a protease. Mutations in this gene have been identified in patients with E3-deficient maple syrup urine disease and lipoamide dehydrogenase deficiency [taken from NCBI Entrez Gene (Gene ID: 1738)].
-
Gen-ID
- 1738
-
NCBI Accession
- NP_000099
-
UniProt
- P09622
-
Pathways
- Ribonucleoside Biosynthetic Process, Cell RedoxHomeostasis
Target
-